A clinical trial to evaluate the efficacy and safety precisely unveiled the comparative effectiveness of Sadangpaniya-phanta,Vayasathapana-kasya ghana tablet and Viyoshadi churna tablet in the treatment of COVID-19
Not Applicable
- Conditions
- Health Condition 1: B338- Other specified viral diseasesHealth Condition 2: B338- Other specified viral diseases
- Registration Number
- CTRI/2021/08/035468
- Lead Sponsor
- Dr Rajesh Adhana
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with mild symptoms of covid-19( Rapid test and RT-PCR) positive case will be enrolled.
Exclusion Criteria
Patient with moderate and sever Covid-19 infection having Pneumonia, Pregnant female patient with covid-19 infection will be excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical recovery will be defined as sustained alleviation of illness based on symptom scores fever,cough,diarrhea,myalgia,dyspnea,all being absent.Timepoint: 10 days
- Secondary Outcome Measures
Name Time Method Symptomatic recovery as cough fever with on SpO2 decline greater than3% and respiratory rate more than 30 per minute and no feeling of weakness and no insomniaTimepoint: 28 days